LAB
Standard BioTools, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.77
+5.45%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.67x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.56x
- Price / sales
- 3.57x
- Price / cash flow
- -3.76x
Enterprise value
- Enterprise value
- -$146.4M
- EV / sales
- -1.73x
- EV / EBITDA
- 1.59x
- EV / EBIT
- 1.83x
- Market cap
- $302.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026